apomorphine hydrochloride

DRUG2 trials

Sponsors

Kyowa Kirin Co., Ltd., Britannia Pharmaceuticals Ltd.

Conditions

Parkinson's Disease

Phase 2

Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy

CompletedNCT00610103

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2007-11-30End: 2008-10-31Updated: 2020-08-28

Phase 3

Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease

CompletedNCT02006121

Britannia Pharmaceuticals Ltd.Parkinson's Disease

Start: 2014-03-03End: 2017-06-08Updated: 2019-07-08

Related Papers

Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.

2025-07-081 citations

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

2018-07-25198 citations